
The certification proves Incode can deliver top‑tier biometric security without compromising user convenience, opening doors to regulated markets and government contracts. It sets a new industry benchmark for cross‑platform liveness assurance.
The biometric market has long grappled with presentation attacks that can bypass face‑recognition systems. Independent testing bodies such as iBeta provide a benchmark by applying the ISO/IEC 30107‑3 standard across increasingly sophisticated attack vectors. Achieving Level 3 PAD means a solution can withstand hyper‑realistic masks, AI‑generated faces and other high‑fidelity spoofs. Incode’s recent certification on both iOS and Android devices therefore signals a rare combination of technical robustness and cross‑platform consistency that few vendors have demonstrated.
Incode’s Deepsight application builds on this foundation by targeting deep‑fake and injection attacks that traditional liveness checks often miss. The zero‑error result—both APCER and BPCER at 0 %—translates into frictionless onboarding while satisfying Identity Assurance Level 2 (IAL‑2) requirements. For enterprises operating in regulated sectors such as finance, healthcare, or government, the ability to verify identity without compromising user experience is a competitive differentiator. Moreover, the recent FedRAMP readiness assessment positions Incode to compete for lucrative U.S. federal biometric contracts.
The certification also dovetails with Incode’s broader ecosystem moves, including its participation in the OpenAge Initiative for reusable age verification. As regulators tighten standards around biometric data privacy, vendors that can prove high‑grade liveness detection across major mobile operating systems will likely capture a larger share of the market. Competitors will need to invest in similar independent testing to stay relevant. Incode’s dual‑platform Level 3 achievement thus sets a new performance bar and could accelerate adoption of secure, user‑friendly biometric solutions worldwide.
Comments
Want to join the conversation?
Loading comments...